Table 2.
NT-proBNP levels and functional outcomes of participants at admission and 90 days.
| Functional outcomes | NT-proBNP, pg/mL | |||
|---|---|---|---|---|
| < 100 (n = 10) | 100–750 (n = 30) | > 750 (n = 27) | P-value | |
| Admission—median (IQR) | ||||
| NIHSS score | 2.5 (2–4) | 3 (2–5) | 5 (3–9) | 0.10 |
| mRS | 3 (2–4) | 3 (2–4) | 3.5 (3–4) | 0.08 |
| BI | 67.5 (50–70) | 62.5 (35–75) | 37.5 (30–70) | 0.14 |
| 90-day—median (IQR) | ||||
| NIHSS score | 1 (0–2) | 1 (0.5–4) | 2 (1–4) | 0.40 |
| mRS | 0.5 (0–2) | 1 (0–3) | 2 (1–4) | 0.23 |
| BI | 97.5 (85–100) | 90 (65–100) | 80 (50–100) | 0.20 |
BI Barthel Index, IQR interquartile range, mRS modified Rankin Scale, NIHSS National Institute of Health Stroke Scale, NT-proBNP N-terminal fragment B-type natriuretic peptide.